Felzartamab (Anti-CD38)
Felzartamab (Anti-CD38) (A2818-GRP)
Products
Description
Felzartamab (Anti-CD38) is a fully human monoclonal antibody directed against the cell surface glycoprotein CD-38 with potential antineoplastic activity. MW : 143.66 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2818 |
| Target | CD markers |